$SNTI Income Statement | Understand Stock

$SNTI

$0.18 -$0.01 (7.06%) Close

$SNTI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 10 months to Dec 31, 2021
Professional fees and other expenses
Franchise tax expense
Collaboration revenue - related party
Grant income
Total revenue
Operating expenses:
Research and development (including related party costs of $12,909 and $14,266 for the year ended December 31, 2025 and 2024, respectively)
Related Party
Total research and development (including related party costs of $12,909 and $14,266 for the year ended December 31, 2025 and 2024, respectively)
General and administrative
Impairment of long-lived assets
Total operating expenses
Loss from operations
Interest and dividend income on investments held in Trust Account
Other income (expense):
Interest income
GeneFab sublease income - related party
Related Party
Total geneFab sublease income - related party
Other income, net
Related Party
Nonrelated Party
Total other income, net
Change in fair value of Preferred Stock Tranche Liability - related party
Change in fair value
GeneFab Option
Change in fair value of GeneFab Economic Share - related party
Change in fair value of GeneFab Note Receivable - related party
Gain on extinguishment of convertible notes
Change in fair value of contingent earnout liability
Total other income, net
Net loss from continuing operations
Net income from discontinued operations
Net loss
Basic and diluted weighted average shares outstanding
Common Class A
Common Class B
Basic and diluted net loss per share
Unrealized loss on investments
Comprehensive loss
Net loss per share from continuing operations, basic (in dollars per share)
Net income (loss) per share from discontinued operations, basic (in dollars per share)
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Weighted-average shares outstanding, basic (in shares)
Weighted-average shares outstanding, diluted (in shares)

Comments